Skip to Main Content
Diseases of the Respiratory Systems, Phase II

BEACON-IPF for the treatment of idiopathic pulmonary fibrosis

What is the purpose of this trial?

The study is for people who: Are 40 years of age or older at screening. Have a current diagnosis of IPF (within 7 years prior to screening). The study will examine whether bexotegrast can slow down or halt the progression of IPF by reducing scar formation (fibrosis) in participants over the study period. The study will also assess what effects bexotegrast has on participants’ lung function. Your participation in the study will last for approximately one year.

Contact Information

For more information about this study, including how to volunteer, contact Danielle Antin-Ozerkis, MD

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    08/13/2024
  • Study HIC
    #2000035682